EcoDrugPlus

Ensembl ID : ENSAOCG00000001170
Gene Symbol: -
Cross references: -
206 Possible Orthologues:

Ensembl ID : ENSAOCG00000011111
Gene Symbol: -
Cross references: -
162 Possible Orthologues:

Ensembl ID : ENSAOCG00000022602
Gene Symbol: -
Cross references: -
200 Possible Orthologues:

Ensembl ID : ENSAOCG00000023760
Gene Symbol: -
Cross references: -
1041 Possible Orthologues:

Ensembl ID : ENSAOCG00000011374
Gene Symbol: -
Cross references: -
213 Possible Orthologues:

Ensembl ID : ENSAOCG00000001183
Gene Symbol: -
Cross references: -
114 Possible Orthologues:

Ensembl ID : ENSAOCG00000001321
Gene Symbol: -
Cross references: -
201 Possible Orthologues:

Ensembl ID : ENSAOCG00000022735
Gene Symbol: -
1 Cross references
232 Possible Orthologues:

Ensembl ID : ENSAOCG00000017837
Gene Symbol: -
Cross references: -
253 Possible Orthologues:

Ensembl ID : ENSAOCG00000013436
Gene Symbol: -
Cross references: -
191 Possible Orthologues:

Ensembl ID : ENSAOCG00000001617
Gene Symbol: -
Cross references: -
209 Possible Orthologues:

Ensembl ID : ENSAOCG00000022778
Gene Symbol: -
Cross references: -
232 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).